Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grinspoon

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
HIV Clinical Trials|March 10, 2017
Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trialMarkella V Zanni, Kathleen Fitch, Corinne Rivard, et al.
AIDS (London, England)|December 24, 2015
Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIVSara E Looby, Kathleen V Fitch, Suman Srinivasa, et al.
The Journal of Infectious Diseases|September 16, 2011
Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patientsTricia H Burdo, Janet Lo, Suhny Abbara, et al.
Obesity (Silver Spring, Md.)|October 18, 2021
Racial and ethnic representation among a sample of nutrition- and obesity-focused professional organizations in the United StatesTiffany L Carson, Michelle I Cardel, Takara L Stanley, et al.
The American Journal of Clinical Nutrition|October 31, 2021
Racial and ethnic representation among a sample of nutrition- and obesity-focused professional organizations in the United StatesTiffany L Carson, Michelle I Cardel, Takara L Stanley, et al.
AIDS (London, England)|July 30, 2005
A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulationJulian Falutz, Soraya Allas, Donald Kotler, et al.
HIV Clinical Trials|April 20, 2010
A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophyJanet M Raboud, Christina Diong, Andrew Carr, et al.
The New England Journal of Medicine|December 7, 2007
Metabolic effects of a growth hormone-releasing factor in patients with HIVJulian Falutz, Soraya Allas, Koenraad Blot, et al.
The Journal of Infectious Diseases|April 19, 2008
Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapyTodd Hulgan, Pablo Tebas, Jeffrey A Canter, et al.
AIDS (London, England)|August 12, 2008
Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulationJulian Falutz, Soraya Allas, Jean-Claude Mamputu, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
HIV Clinical Trials|March 10, 2017
Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trialMarkella V Zanni, Kathleen Fitch, Corinne Rivard, et al.
AIDS (London, England)|December 24, 2015
Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIVSara E Looby, Kathleen V Fitch, Suman Srinivasa, et al.
The Journal of Infectious Diseases|September 16, 2011
Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patientsTricia H Burdo, Janet Lo, Suhny Abbara, et al.
Obesity (Silver Spring, Md.)|October 18, 2021
Racial and ethnic representation among a sample of nutrition- and obesity-focused professional organizations in the United StatesTiffany L Carson, Michelle I Cardel, Takara L Stanley, et al.
The American Journal of Clinical Nutrition|October 31, 2021
Racial and ethnic representation among a sample of nutrition- and obesity-focused professional organizations in the United StatesTiffany L Carson, Michelle I Cardel, Takara L Stanley, et al.
AIDS (London, England)|July 30, 2005
A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulationJulian Falutz, Soraya Allas, Donald Kotler, et al.
HIV Clinical Trials|April 20, 2010
A meta-analysis of six placebo-controlled trials of thiazolidinedione therapy for HIV lipoatrophyJanet M Raboud, Christina Diong, Andrew Carr, et al.
The New England Journal of Medicine|December 7, 2007
Metabolic effects of a growth hormone-releasing factor in patients with HIVJulian Falutz, Soraya Allas, Koenraad Blot, et al.
The Journal of Infectious Diseases|April 19, 2008
Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapyTodd Hulgan, Pablo Tebas, Jeffrey A Canter, et al.
AIDS (London, England)|August 12, 2008
Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulationJulian Falutz, Soraya Allas, Jean-Claude Mamputu, et al.
Pageof 11